Bowhead Specialty (BOW) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
5 Oct, 2026Executive summary
Merger agreement dated August 2, 2026 provides $34.00 cash per eligible share; Parent would own 100% after closing and the shares would cease public trading.
Closing was anticipated before year-end 2026, subject to stockholder approval and other conditions; estimated funding need is $1.0355 billion, with no financing condition.
Parent expects to operate the business substantially as before, as a strategically aligned but operationally independent entity, retaining its brand, leadership, core operating model and broker relationships.
Voting matters and shareholder proposals
Three proposals: adopt the merger agreement, approve merger-related named executive compensation on a non-binding advisory basis, and authorize adjournment if needed to solicit votes; the Board recommends FOR all three.
Merger approval requires at least a majority of all outstanding shares and a majority of outstanding Subject Shares, excluding Parent and its subsidiaries and Recused Directors; each share carries one vote.
The compensation and adjournment proposals each require a majority of shares present and entitled to vote; compensation approval is advisory and not a closing condition.
GPC Fund, holding 27.2% as of the Record Date, and director and executive stockholders indicated intent to vote FOR the merger proposal.
Board of directors and corporate governance
Non-Recused Directors, constituting a quorum, unanimously found the transaction fair, advisable and in stockholders’ best interests and recommended approval after consulting legal and financial advisors.
Four directors were recused over actual or potential conflicts involving Parent or related commercial ties; Non-Recused Directors exercised full Board authority, without a separate special committee.
Negotiations raised the offer from $31 to $34 per share; the final price represented premiums of 11% to unaffected closing price, 12% to 30-day VWAP and 19% to 60-day VWAP.
Ardea concluded $34 was fair from a financial point of view to eligible holders; KBW separately opined that the consideration was fair to Parent.
Latest events from Bowhead Specialty
- $34 cash-per-share take-private deal advances to a November 13, 2026 vote.BOW
Proxy filing - Shareholders to vote on a $34.00 per share cash merger, with board unanimous support.BOW
Proxy filing - Shareholders will vote on a $34.00 per share cash merger, unanimously recommended by the board.BOW
Proxy filing - Merger with American Family Mutual Insurance Company announced, pending stockholder approval.BOW
Proxy filing - Merger agreement approved: stockholders to receive $34/share; Bowhead to go private post-closing.BOW
Proxy filing - Q2 2026 saw 28.2% premium growth and a $1.2B merger agreement with American Family.BOW
Q2 2026 - Premiums up 24%, net income up 40%, and digital underwriting surged in Q1 2026.BOW
Q1 2026 - Gross written premiums surged 50.4% and adjusted net income reached $7.9M in Q2 2024.BOW
Q2 2024 - Premiums up 37% to $696M in 2024; Q4 net income up 143%; 2025 targets 20% growth, mid-teens ROE.BOW
Q4 2024